FDA inspection
Avista Pharma Solutions, Inc.: FDA inspection ending Jul 25, 2025
FDA inspection 1278383 · Voluntary Action Indicated (VAI) · Agawam, MA
Key facts
| Inspection ID | 1278383 |
|---|---|
| Firm | Avista Pharma Solutions, Inc. |
| FEI number | 1220785 |
| Address | 104 Gold St |
| City | Agawam |
| State | MA |
| ZIP | 01001 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Jul 25, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data